Reply to John L. Frater's Letter to the Editor: Use of Laboratory Hematology Data in Melanoma Research: Comments on 'A Novel Prognostic Biomarker for Cutaneous Malignant Melanoma: Red Cell Distribution Width (RDW) to Lymphocyte Ratio'